Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Hemophilia B Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Europe Hemophilia B Drug Market Segmentations:
By Player:
CSL Behring
REVO Biologics
Dimension Therapeutics
Asklepios
OPKO Health
Pfizer
Emergent BioSolutions
Sangamo BioSciences
Amarna Therapeutics
Biogen
Novo Nordisk
Catalyst Biosciences
Dong-A Socio
UniQure
Swedish Orphan Biovitrum
Alnylam Pharmaceuticals
Kedrion
Baxter
Spark Therapeutics
Grifols
By Type:
Type 1
Type 2
Type 3
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Region:
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Poland
-
Russia
-
Switzerland
-
Turkey
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Iceland
-
Benelux (Belgium, Netherlands, and Luxembourg)
-
Belgium
-
Netherlands
-
Luxembourg
-
Baltic States (Estonia, Latvia, and Lithuania)
-
Estonia
-
Latvia
-
Lithuania
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hemophilia B Drug Market
-
1.3 Market Segment by Type
1.3.1 Europe Hemophilia B Drug Market Size and Growth Rate of Type 1 from 2014 to 2026
1.3.2 Europe Hemophilia B Drug Market Size and Growth Rate of Type 2 from 2014 to 2026
1.3.3 Europe Hemophilia B Drug Market Size and Growth Rate of Type 3 from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Europe Hemophilia B Drug Market Size and Growth Rate of End-User 1 from 2014 to 2026
1.4.2 Europe Hemophilia B Drug Market Size and Growth Rate of End-User 2 from 2014 to 2026
1.4.3 Europe Hemophilia B Drug Market Size and Growth Rate of End-User 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Germany Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.2 UK Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.3 France Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Italy Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Spain Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Poland Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Russia Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Switzerland Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.9 Turkey Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Hemophilia B Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Venders
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hemophilia B Drug by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Hemophilia B Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hemophilia B Drug by Major End-Users
4.4.1 Market Size and Growth Rate of Hemophilia B Drug for End-Users 1
4.4.2 Market Size and Growth Rate of Hemophilia B Drug for End-Users 2
4.4.3 Market Size and Growth Rate of Hemophilia B Drug for End-Users 3
5 Market Analysis by Major Regions
-
5.1 Europe Hemophilia B Drug Production Analysis by Top Regions
-
5.2 Europe Hemophilia B Drug Consumption Analysis by Top Regions
-
5.3 Europe Hemophilia B Drug Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 Germany Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.2 UK Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.3 France Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.4 Italy Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.5 Spain Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.6 Poland Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.7 Russia Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.8 Switzerland Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.9 Turkey Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Production, Import, Consumption and Export Analysis
6 Product Circulation of Hemophilia B Drug Market among Top Countries
-
6.1 Top 5 Export Countries in Hemophilia B Drug Market from 2014 to 2019
-
6.1.1 Top 5 Export Countries’ Export Value Analysis in Hemophilia B Drug Market from 2014 to 2019
-
6.1.2 Top 5 Export Countries’ Export Volume Analysis in Hemophilia B Drug Market from 2014 to 2019
-
6.2 Top 5 Import Countries in Hemophilia B Drug Market from 2014 to 2019
-
6.2.1 Top 5 Import Countries’ Import Value Analysis in Hemophilia B Drug Market from 2014 to 2019
-
6.2.2 Top 5 Import Countries’ Import Volume Analysis in Hemophilia B Drug Market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7. Germany Hemophilia B Drug Landscape Analysis
-
7.1 Germany Hemophilia B Drug Landscape Analysis by Major Types
-
7.2 Germany Hemophilia B Drug Landscape Analysis by Major End-Users
8. UK Hemophilia B Drug Landscape Analysis
-
8.1 UK Hemophilia B Drug Landscape Analysis by Major Types
-
8.2 UK Hemophilia B Drug Landscape Analysis by Major End-Users
9. France Hemophilia B Drug Landscape Analysis
-
9.1 France Hemophilia B Drug Landscape Analysis by Major Types
-
9.2 France Hemophilia B Drug Landscape Analysis by Major End-Users
10. Italy Hemophilia B Drug Landscape Analysis
-
10.1 Italy Hemophilia B Drug Landscape Analysis by Major Types
-
10.2 Italy Hemophilia B Drug Landscape Analysis by Major End-Users
11. Spain Hemophilia B Drug Landscape Analysis
-
11.1 Spain Hemophilia B Drug Landscape Analysis by Major Types
-
11.2 Spain Hemophilia B Drug Landscape Analysis by Major End-Users
12. Poland Hemophilia B Drug Landscape Analysis
-
12.1 Poland Hemophilia B Drug Landscape Analysis by Major Types
-
12.2 Poland Hemophilia B Drug Landscape Analysis by Major End-Users
13. Russia Hemophilia B Drug Landscape Analysis
-
13.1 Russia Hemophilia B Drug Landscape Analysis by Major Types
-
13.2 Russia Hemophilia B Drug Landscape Analysis by Major End-Users
14. Switzerland Hemophilia B Drug Landscape Analysis
-
14.1 Switzerland Hemophilia B Drug Landscape Analysis by Major Types
-
14.2 Switzerland Hemophilia B Drug Landscape Analysis by Major End-Users
15. Turkey Hemophilia B Drug Landscape Analysis
-
15.1 Turkey Hemophilia B Drug Landscape Analysis by Major Types
-
15.2 Turkey Hemophilia B Drug Landscape Analysis by Major End-Users
16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Landscape Analysis
-
16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Landscape Analysis by Major Types
-
16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Landscape Analysis by Major End-Users
-
16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Landscape Analysis by Top Countries
-
16.3.1 Denmark Hemophilia B Drug Market Volume and Growth Rate
-
16.3.2 Finland Hemophilia B Drug Market Volume and Growth Rate
-
16.3.3 Norway Hemophilia B Drug Market Volume and Growth Rate
-
16.3.4 Sweden Hemophilia B Drug Market Volume and Growth Rate
-
16.3.6 Iceland Hemophilia B Drug Market Volume and Growth Rate
17 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Landscape Analysis
-
17.1 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Landscape Analysis by Major Types
-
17.2 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Landscape Analysis by Major End-Users
-
17.3 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Landscape Analysis by Top Countries
-
17.3.1 Belgium Hemophilia B Drug Market Volume and Growth Rate
-
17.3.2 Netherlands Hemophilia B Drug Market Volume and Growth Rate
-
17.3.3 Luxembourg Hemophilia B Drug Market Volume and Growth Rate
18 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Landscape Analysis
-
18.1 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Landscape Analysis by Major Types
-
18.2 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Landscape Analysis by Major End-Users
-
18.3 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Landscape Analysis by Top Countries
-
18.3.1 Estonia Hemophilia B Drug Market Volume and Growth Rate
-
18.3.2 Latvia Hemophilia B Drug Market Volume and Growth Rate
-
18.3.3 Lithuania Hemophilia B Drug Market Volume and Growth Rate
19 Major Players Profiles
19.1 CSL Behring
19.1.1 CSL Behring Company Profile and Development Status
19.1.2 Market Performance
19.1.3 Product and Service Introduction
19.2 REVO Biologics
19.2.1 REVO Biologics Company Profile and Development Status
19.2.2 Market Performance
19.2.3 Product and Service Introduction
19.3 Dimension Therapeutics
19.3.1 Dimension Therapeutics Company Profile and Development Status
19.3.2 Market Performance
19.3.3 Product and Service Introduction
19.4 Asklepios
19.4.1 Asklepios Company Profile and Development Status
19.4.2 Market Performance
19.4.3 Product and Service Introduction
19.5 OPKO Health
19.5.1 OPKO Health Company Profile and Development Status
19.5.2 Market Performance
19.5.3 Product and Service Introduction
19.6 Pfizer
19.6.1 Pfizer Company Profile and Development Status
19.6.2 Market Performance
19.6.3 Product and Service Introduction
19.7 Emergent BioSolutions
19.7.1 Emergent BioSolutions Company Profile and Development Status
19.7.2 Market Performance
19.7.3 Product and Service Introduction
19.8 Sangamo BioSciences
19.8.1 Sangamo BioSciences Company Profile and Development Status
19.8.2 Market Performance
19.8.3 Product and Service Introduction
19.9 Amarna Therapeutics
19.9.1 Amarna Therapeutics Company Profile and Development Status
19.9.2 Market Performance
19.9.3 Product and Service Introduction
19.10 Biogen
19.10.1 Biogen Company Profile and Development Status
19.10.2 Market Performance
19.10.3 Product and Service Introduction
19.11 Novo Nordisk
19.11.1 Novo Nordisk Company Profile and Development Status
19.11.2 Market Performance
19.11.3 Product and Service Introduction
19.12 Catalyst Biosciences
19.12.1 Catalyst Biosciences Company Profile and Development Status
19.12.2 Market Performance
19.12.3 Product and Service Introduction
19.13 Dong-A Socio
19.13.1 Dong-A Socio Company Profile and Development Status
19.13.2 Market Performance
19.13.3 Product and Service Introduction
19.14 UniQure
19.14.1 UniQure Company Profile and Development Status
19.14.2 Market Performance
19.14.3 Product and Service Introduction
19.15 Swedish Orphan Biovitrum
19.15.1 Swedish Orphan Biovitrum Company Profile and Development Status
19.15.2 Market Performance
19.15.3 Product and Service Introduction
19.16 Alnylam Pharmaceuticals
19.16.1 Alnylam Pharmaceuticals Company Profile and Development Status
19.16.2 Market Performance
19.16.3 Product and Service Introduction
19.17 Kedrion
19.17.1 Kedrion Company Profile and Development Status
19.17.2 Market Performance
19.17.3 Product and Service Introduction
19.18 Baxter
19.18.1 Baxter Company Profile and Development Status
19.18.2 Market Performance
19.18.3 Product and Service Introduction
19.19 Spark Therapeutics
19.19.1 Spark Therapeutics Company Profile and Development Status
19.19.2 Market Performance
19.19.3 Product and Service Introduction
19.20 Grifols
19.20.1 Grifols Company Profile and Development Status
19.20.2 Market Performance
19.20.3 Product and Service Introduction
The List of Tables and Figures (Totals 112 Figures and 142 Tables)
-
Figure Product Picture
Figure Europe Hemophilia B Drug Market Size and Growth Rate of Type 1 from 2014 to 2026
Figure Europe Hemophilia B Drug Market Size and Growth Rate of Type 2 from 2014 to 2026
Figure Europe Hemophilia B Drug Market Size and Growth Rate of Type 3 from 2014 to 2026
Figure Europe Hemophilia B Drug Market Size and Growth Rate of End-User 1 from 2014 to 2026
Figure Europe Hemophilia B Drug Market Size and Growth Rate of End-User 2 from 2014 to 2026
Figure Europe Hemophilia B Drug Market Size and Growth Rate of End-User 3 from 2014 to 2026
-
Figure Germany Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure UK Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure France Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Switzerland Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Denmark Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Finland Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Norway Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Sweden Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Iceland Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Netherlands Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Luxembourg Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Estonia Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Latvia Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Lithuania Hemophilia B Drug Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Hemophilia B Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Hemophilia B Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hemophilia B Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Hemophilia B Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Hemophilia B Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Hemophilia B Drug by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of End-User 1
Figure Market Size and Growth Rate of End-User 2
Figure Market Size and Growth Rate of End-User 3
-
Table Europe Hemophilia B Drug Production by Major Regions
-
Table Europe Hemophilia B Drug Production Share by Major Regions
-
Figure Europe Hemophilia B Drug Production Share by Major Countries and Regions in 2014
-
Table Europe Hemophilia B Drug Consumption by Major Regions
-
Table Europe Hemophilia B Drug Consumption Share by Major Regions
-
Table Germany Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table UK Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table France Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Italy Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Spain Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Poland Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Russia Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Switzerland Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Turkey Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Hemophilia B Drug Market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Hemophilia B Drug Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Hemophilia B Drug Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Hemophilia B Drug Market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table Germany Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Germany Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Germany Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Germany Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table UK Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table UK Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table UK Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table UK Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table France Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table France Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table France Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table France Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Italy Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Italy Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Italy Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Italy Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Spain Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Spain Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Spain Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Spain Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Poland Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Poland Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Poland Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Poland Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Russia Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Russia Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Russia Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Russia Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Switzerland Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Switzerland Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Switzerland Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Switzerland Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Turkey Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Turkey Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Turkey Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Turkey Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Consumption by Major Countries from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia B Drug Consumption Share by Major Countries from 2014 to 2026
-
Figure Denmark Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Finland Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Norway Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Sweden Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Iceland Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Consumption by Major Countries from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia B Drug Consumption Share by Major Countries from 2014 to 2026
-
Figure Belgium Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Netherlands Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Luxembourg Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Consumption by Types from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Consumption Share by Types from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Consumption by End-Users from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Consumption Share by End-Users from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Consumption by Major Countries from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia B Drug Consumption Share by Major Countries from 2014 to 2026
-
Figure Estonia Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Latvia Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
-
Figure Lithuania Countries Hemophilia B Drug Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of CSL Behring
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring
Figure Sales and Growth Rate Analysis of CSL Behring
Figure Revenue and Market Share Analysis of CSL Behring
Table Product and Service Introduction of CSL Behring
Table Company Profile and Development Status of REVO Biologics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of REVO Biologics
Figure Sales and Growth Rate Analysis of REVO Biologics
Figure Revenue and Market Share Analysis of REVO Biologics
Table Product and Service Introduction of REVO Biologics
Table Company Profile and Development Status of Dimension Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dimension Therapeutics
Figure Sales and Growth Rate Analysis of Dimension Therapeutics
Figure Revenue and Market Share Analysis of Dimension Therapeutics
Table Product and Service Introduction of Dimension Therapeutics
Table Company Profile and Development Status of Asklepios
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Asklepios
Figure Sales and Growth Rate Analysis of Asklepios
Figure Revenue and Market Share Analysis of Asklepios
Table Product and Service Introduction of Asklepios
Table Company Profile and Development Status of OPKO Health
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OPKO Health
Figure Sales and Growth Rate Analysis of OPKO Health
Figure Revenue and Market Share Analysis of OPKO Health
Table Product and Service Introduction of OPKO Health
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Emergent BioSolutions
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions
Figure Sales and Growth Rate Analysis of Emergent BioSolutions
Figure Revenue and Market Share Analysis of Emergent BioSolutions
Table Product and Service Introduction of Emergent BioSolutions
Table Company Profile and Development Status of Sangamo BioSciences
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo BioSciences
Figure Sales and Growth Rate Analysis of Sangamo BioSciences
Figure Revenue and Market Share Analysis of Sangamo BioSciences
Table Product and Service Introduction of Sangamo BioSciences
Table Company Profile and Development Status of Amarna Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amarna Therapeutics
Figure Sales and Growth Rate Analysis of Amarna Therapeutics
Figure Revenue and Market Share Analysis of Amarna Therapeutics
Table Product and Service Introduction of Amarna Therapeutics
Table Company Profile and Development Status of Biogen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
Figure Sales and Growth Rate Analysis of Biogen
Figure Revenue and Market Share Analysis of Biogen
Table Product and Service Introduction of Biogen
Table Company Profile and Development Status of Novo Nordisk
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
Figure Sales and Growth Rate Analysis of Novo Nordisk
Figure Revenue and Market Share Analysis of Novo Nordisk
Table Product and Service Introduction of Novo Nordisk
Table Company Profile and Development Status of Catalyst Biosciences
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalyst Biosciences
Figure Sales and Growth Rate Analysis of Catalyst Biosciences
Figure Revenue and Market Share Analysis of Catalyst Biosciences
Table Product and Service Introduction of Catalyst Biosciences
Table Company Profile and Development Status of Dong-A Socio
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dong-A Socio
Figure Sales and Growth Rate Analysis of Dong-A Socio
Figure Revenue and Market Share Analysis of Dong-A Socio
Table Product and Service Introduction of Dong-A Socio
Table Company Profile and Development Status of UniQure
Table Sales, Revenue, Sales Price and Gross Margin Analysis of UniQure
Figure Sales and Growth Rate Analysis of UniQure
Figure Revenue and Market Share Analysis of UniQure
Table Product and Service Introduction of UniQure
Table Company Profile and Development Status of Swedish Orphan Biovitrum
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Swedish Orphan Biovitrum
Figure Sales and Growth Rate Analysis of Swedish Orphan Biovitrum
Figure Revenue and Market Share Analysis of Swedish Orphan Biovitrum
Table Product and Service Introduction of Swedish Orphan Biovitrum
Table Company Profile and Development Status of Alnylam Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
Table Product and Service Introduction of Alnylam Pharmaceuticals
Table Company Profile and Development Status of Kedrion
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion
Figure Sales and Growth Rate Analysis of Kedrion
Figure Revenue and Market Share Analysis of Kedrion
Table Product and Service Introduction of Kedrion
Table Company Profile and Development Status of Baxter
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
Figure Sales and Growth Rate Analysis of Baxter
Figure Revenue and Market Share Analysis of Baxter
Table Product and Service Introduction of Baxter
Table Company Profile and Development Status of Spark Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics
Figure Sales and Growth Rate Analysis of Spark Therapeutics
Figure Revenue and Market Share Analysis of Spark Therapeutics
Table Product and Service Introduction of Spark Therapeutics
Table Company Profile and Development Status of Grifols
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols
Figure Sales and Growth Rate Analysis of Grifols
Figure Revenue and Market Share Analysis of Grifols
Table Product and Service Introduction of Grifols
-
